Literature DB >> 3040659

Normal alveolar epithelial lining fluid contains high levels of glutathione.

A M Cantin, S L North, R C Hubbard, R G Crystal.   

Abstract

The epithelial cells on the alveolar surface of the human lower respiratory tract are vulnerable to toxic oxidants derived from inhaled pollutants or inflammatory cells. Although these lung cells have intracellular antioxidants, these defenses may be insufficient to protect the epithelial surface against oxidants present at the alveolar surface. This study demonstrates that the epithelial lining fluid (ELF) of the lower respiratory tract contains large amounts of the sulfhydryl-containing antioxidant glutathione (GSH). The total glutathione (the reduced form GSH and the disulfide GSSG) concentration of normal ELF was 140-fold higher than that in plasma of the same individuals, and 96% of the glutathione in ELF was in the reduced form. Compared with nonsmokers, cigarette smokers had 80% higher levels of ELF total glutathione, 98% of which was in the reduced form. Studies of cultured lung epithelial cells and fibroblasts demonstrated that these concentrations of reduced glutathione were sufficient to protect these cells against the burden of H2O2 in the range released by alveolar macrophages removed from the lower respiratory tract of nonsmokers and smokers, respectively, suggesting that the glutathione present in the alveolar ELF of normal individuals likely contributes to the protective screen against oxidants in the extracellular milieu of the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040659     DOI: 10.1152/jappl.1987.63.1.152

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  184 in total

1.  Nitrogen dioxide depletes uric acid and ascorbic acid but not glutathione from lung lining fluid.

Authors:  F J Kelly; T D Tetley
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Pulmonary oxidative stress response in young children with cystic fibrosis.

Authors:  J Hull; P Vervaart; K Grimwood; P Phelan
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

3.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

4.  Ablation of glutaredoxin-1 attenuates lipopolysaccharide-induced lung inflammation and alveolar macrophage activation.

Authors:  Scott W Aesif; Vikas Anathy; Ine Kuipers; Amy S Guala; Jessica N Reiss; Ye-Shih Ho; Yvonne M W Janssen-Heininger
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-10       Impact factor: 6.914

5.  Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Leandrea Burwell; Meredith S Brown; Lou Ann S Brown
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

Review 6.  Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance.

Authors:  D R Baldwin; D Honeybourne; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 7.  Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease?

Authors:  A V Wisnewski; M Jones
Journal:  Clin Exp Allergy       Date:  2010-06-07       Impact factor: 5.018

Review 8.  The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema.

Authors:  J E Gadek; E R Pacht
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 9.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

10.  Human lung expresses unique gamma-glutamyl transpeptidase transcripts.

Authors:  L A Wetmore; C Gerard; J M Drazen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.